Surrozen (SRZN) Competitor Comparison
We are evaluating the key criteria listed to compare Surrozen (SRZN) against its competitors in the Biotechnology industry.
Market Capitalization
319 / 368Gross Profits
0 / 278Total Revenue
179 / 300EBITDA
113 / 337Free Cashflow
132 / 352Quick Ratio
137 / 357Earnings per Share
348 / 359Dividend yield
0 / 6Total Cash
265 / 358Performance 3 years
295 / 368Performance 5 years
292 / 368Performance 10 years
260 / 368Linearity 3 years
314 / 368Linearity 5 years
279 / 368Linearity 10 years
238 / 367Total Rank
28 / 368Dividend Rank
12 / 368Valuation Rank
12 / 368Piotroski Rank
30 / 368Muliplier Rank
212 / 368Market Capitalization - SRZN ranking 319 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.